HealthDay News — A recall of more than a dozen types of Philips breathing machines because of potential cancer risks has millions of Americans struggling to find replacements to deal with sleep disorders, breathing problems, and respiratory emergencies.

The recall involves certain Respironics bilevel positive air pressure (BiPAP), continuous positive air pressure (CPAP), and ventilator machines made before April 26, The New York Times reported.

The U.S. Food and Drug Administration said earlier this summer that the recalled machines pose risks that could be “life-threatening, cause permanent impairment and require medical intervention.” Polyester-based polyurethane foam that reduces sound and vibration in the machines can break down and result in users breathing in chemicals or swallowing or inhaling black debris, possibly resulting in asthma, skin and respiratory tract irritation, and “toxic and carcinogenic effects” to organs, including the kidneys and liver, the agency warned.


Continue Reading

The FDA has ordered Philips to submit a repair-and-replacement program for the faulty components. Beyond providing the agency with a plan, Philips must conduct extensive testing and the FDA will then review the data before any machines can be sent to patients.

About 2 million of the recalled machines were in use in the United States, according to Mario Fante, a spokesman for Royal Philips, the parent company of Respironics. That is about half of the total number of units worldwide, The Times reported. These machines are used at home by some of the estimated 24 million Americans with obstructive sleep apnea. Customers with recalled machines should register their products and consult their doctors, Philips advised.

The company is working “expeditiously” but is “not able to provide an immediate solution,” Fante told The Times. Philips is “already producing repair kits and replacement devices in large quantities” of about 55,000 units a week that have not yet been approved for shipping, he said. The company is not taking orders for sleep therapy devices for new patients.

The New York Times Article

More Information